174 related articles for article (PubMed ID: 31557077)
1. LOW FREE (BUT NOT TOTAL) 25-HYDROXYVITAMIN D LEVELS IN SUBJECTS WITH NORMOCALCEMIC HYPERPARATHYROIDISM.
Wang X; Meng L; Su C; Shapses SA
Endocr Pract; 2020 Feb; 26(2):174-178. PubMed ID: 31557077
[No Abstract] [Full Text] [Related]
2. Lower total 25-hydroxyvitamin D but no difference in calculated or measured free 25-hydroxyvitamin D serum levels in patients with primary hyperparathyroidism.
Meng L; Su C; Shapses SA; Al-Dayyeni A; He Y; Wang X
J Steroid Biochem Mol Biol; 2020 May; 199():105616. PubMed ID: 32027935
[TBL] [Abstract][Full Text] [Related]
3. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D-binding protein levels in female patients with primary hyperparathyroidism.
Wang X; Shapses SA; Wei S; Sukumar D; Ghosh J
Endocr Pract; 2013; 19(4):609-13. PubMed ID: 23425651
[TBL] [Abstract][Full Text] [Related]
5. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
Chen G; Xue Y; Zhang Q; Xue T; Yao J; Huang H; Liang J; Li L; Lin W; Lin L; Shi L; Cai L; Wen J
J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199
[TBL] [Abstract][Full Text] [Related]
6. FREE AND BIOAVAILABLE 25-HYDROXYVITAMIN D LEVELS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM.
Wang X; Shapses SA; Al-Hraishawi H
Endocr Pract; 2017 Jan; 23(1):66-71. PubMed ID: 27682354
[TBL] [Abstract][Full Text] [Related]
7. Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis.
Victor F; Pereira Lemos AL; de Holanda Ribas AM; Bandeira L; Pimentel JH; de Andrade Damázio LO; Bandeira F
Int J Endocrinol; 2022; 2022():4558236. PubMed ID: 35437440
[TBL] [Abstract][Full Text] [Related]
8. Dietary vitamin D intake is not associated with 25-hydroxyvitamin D3 or parathyroid hormone in elderly subjects, whereas the calcium-to-phosphate ratio affects parathyroid hormone.
Jungert A; Neuhäuser-Berthold M
Nutr Res; 2013 Aug; 33(8):661-7. PubMed ID: 23890356
[TBL] [Abstract][Full Text] [Related]
9. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
Chertok Shacham E; Maman N; Lazareva T; Masalha R; Mahagna L; Sela G; Ishay A
Front Endocrinol (Lausanne); 2023; 14():1152464. PubMed ID: 37065752
[TBL] [Abstract][Full Text] [Related]
10. IDENTIFYING PARATHYROID HORMONE DISORDERS AND THEIR PHENOTYPES THROUGH A BONE HEALTH SCREENING PANEL: IT'S NOT SIMPLE VITAMIN D DEFICIENCY!
Majid H; Khan AH; Riaz M; Karimi H; Talati J
Endocr Pract; 2016 Jul; 22(7):814-21. PubMed ID: 27018622
[TBL] [Abstract][Full Text] [Related]
11. The effects of season (spring versus autumn) on diagnosis of normocalcemic primary hyperparathyroidism.
Basińska-Lewandowska M; Lewiński A; Lewandowski KC; Skowrońska-Jóźwiak E
Front Endocrinol (Lausanne); 2022; 13():1013362. PubMed ID: 36187131
[TBL] [Abstract][Full Text] [Related]
12. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.
Guo Y; Wang Q; Lu C; Fan P; Li J; Luo X; Chen D
BMC Endocr Disord; 2020 Jan; 20(1):5. PubMed ID: 31914999
[TBL] [Abstract][Full Text] [Related]
13. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.
Lemos ALP; Andrade SRL; Pontes LLH; Teixeira PMC; Bandeira E; Bandeira LC; Bandeira F
Kidney Blood Press Res; 2019; 44(5):1189-1195. PubMed ID: 31542783
[TBL] [Abstract][Full Text] [Related]
14. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
[TBL] [Abstract][Full Text] [Related]
15. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
16. All 25-hydroxyvitamin D-deficient Indian postmenopausal women do not have secondary hyperparathyroidism.
Dixit V; Tripathi RL; Dhanwal DK
Arch Osteoporos; 2018 May; 13(1):62. PubMed ID: 29806069
[TBL] [Abstract][Full Text] [Related]
17. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
[TBL] [Abstract][Full Text] [Related]
18. Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.
Streeten EA; Rogstad AS; Flammer KM; Zarbalian K; Ryan K; Horwitz M; Holick MF; Shelton J
Endocr Pract; 2013; 19(1):91-9. PubMed ID: 23186957
[TBL] [Abstract][Full Text] [Related]
19. Total and free vitamin D metabolites in patients with primary hyperparathyroidism.
Meng L; Su C; Shapses SA; Wang X
J Endocrinol Invest; 2022 Feb; 45(2):301-307. PubMed ID: 34282553
[TBL] [Abstract][Full Text] [Related]
20. 25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy.
Wang X; Sheng Z; Meng L; Su C; Trooskin S; Shapses SA
Front Endocrinol (Lausanne); 2019; 10():171. PubMed ID: 30972023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
